IMPACT OF DUPILUMAB ON SYSTEMIC CORTICOSTEROID AND ANTIBIOTIC USE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION: RESULTS FROM THE BOREAS AND NOTUS TRIALS